293
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Stage classification of IgG4-related dacryoadenitis and sialadenitis by the serum cytokine environment

, , , , , , & show all
Pages 1004-1008 | Received 29 Nov 2017, Accepted 22 Jan 2018, Published online: 23 Feb 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Motohisa Yamamoto, Ken-ichi Takano, Ryuta Kamekura, Satsuki Aochi, Chisako Suzuki, Shingo Ichimiya, Hiroshi Nakase, Tetsuo Himi & Hiroki Takahashi. (2019) Interleukin 5-producing ST2+ memory Th2 cells in IgG4-related dacryoadenitis and sialadenitis. Modern Rheumatology 29:5, pages 856-860.
Read now
Tomoe Yoshikawa, Tomohiro Watanabe, Kosuke Minaga, Ken Kamata & Masatoshi Kudo. (2019) Cytokines produced by innate immune cells in IgG4-related disease. Modern Rheumatology 29:2, pages 219-225.
Read now

Articles from other publishers (9)

Agata Burska, Javier Rodríguez-Carrio, Robert Biesen, Willem A Dik, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, PG Conaghan, Marjan Versnel & Ed Vital. (2023) Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD Open 9:1, pages e002876.
Crossref
Javier Rodríguez-Carrio, Agata Burska, P G Conaghan, Willem A Dik, Robert Biesen, Maija-Leena Eloranta, Giulio Cavalli, Marianne Visser, Dimitrios T Boumpas, George Bertsias, Marie Wahren-Herlenius, Jan Rehwinkel, Marie-Louise Frémond, Mary K Crow, Lars Ronnblom, Ed Vital & Marjan Versnel. (2023) Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD Open 9:1, pages e002864.
Crossref
Octavio Caba, Carmelo Diéguez-Castillo, Joaquina Martínez-Galán, Irene González-Cebrián & Cristina Jiménez-Luna. (2023) Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma. World Journal of Gastrointestinal Oncology 15:2, pages 268-275.
Crossref
Sai‐Nan Min, Meng‐Qi Zhu, Xiang‐Di Mao, Wei Li, Tai Wei, Mei Mei, Yan Zhang, Li‐Ling Wu, Guang‐Yan Yu & Xin Cong. (2022) Contribution of Interleukin‐4–Induced Epithelial Cell Senescence to Glandular Fibrosis in IgG4‐Related Sialadenitis . Arthritis & Rheumatology 74:6, pages 1070-1082.
Crossref
Motohisa Yamamoto, Noritada Yoshikawa & Hirotoshi Tanaka. (2022) Efficacy of dupilumab reveals therapeutic target for IgG4-related disease: simultaneous control of inflammation and fibrosis. Annals of the Rheumatic Diseases 81:3, pages e50-e50.
Crossref
Akane Hara, Tomohiro Watanabe, Kosuke Minaga, Tomoe Yoshikawa, Ken Kamata & Masatoshi Kudo. (2021) Biomarkers in autoimmune pancreatitis and immunoglobulin G4-related disease. World Journal of Gastroenterology 27:19, pages 2257-2269.
Crossref
Qicai Liu, Yunfeng Lin, Sheng Zhang, Min Chen, Qingquan Chen, Hongbin Rui, Fang Wang, Xiaoting Lv & Feng Gao. (2020) CGRP-Mediated Prolactin Upregulation: a Possible Pathomechanism in IgG4-Related Disease. Inflammation 44:2, pages 536-548.
Crossref
Satoshi Takanashi, Jun Kikuchi, Takanori Sasaki, Mitsuhiro Akiyama, Hidekata Yasuoka, Keiko Yoshimoto, Noriyasu Seki, Kunio Sugahara, Kenji Chiba, Yuko Kaneko & Tsutomu Takeuchi. (2021) Lymphadenopathy in IgG4-related disease: a phenotype of severe activity and poor prognosis, with eotaxin-3 as a new biomarker. Rheumatology 60:2, pages 967-975.
Crossref
Motohisa Yamamoto, Hiroki Takahashi & Hirotoshi Tanaka. (2019) Differences in clinical features of immunoglobulin G4‐related disease between older and younger patients. Geriatrics & Gerontology International 19:6, pages 564-565.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.